Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDUSTRY × Female Breast Carcinoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 678 Breast Neoplasms 582 Neoplasms 467 Colorectal Neoplasms 298 Prostatic Neoplasms 262 Neoplasm Metastasis 255 Melanoma 240 Ovarian Neoplasms 228 Recurrence 215 Lung Neoplasms 203 Multiple Myeloma 194 Lymphoma, Non-Hodgkin 154 Pancreatic Neoplasms 152 Leukemia, Myeloid, Acute 141 Carcinoma, Hepatocellular 141 Stomach Neoplasms 136 Lymphoma 131 Carcinoma, Renal Cell 127 Glioblastoma 118 Head and Neck Neoplasms 112 Squamous Cell Carcinoma of Head and Neck 110 Lymphoma, Follicular 105 Leukemia, Lymphocytic, Chronic, B-Cell 98 Lymphoma, Large B-Cell, Diffuse 96 Leukemia 96 Small Cell Lung Carcinoma 95 Brain Neoplasms 90 Carcinoma 82 Uterine Cervical Neoplasms 76 Triple Negative Breast Neoplasms 72

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02540330 2024-04-03

007

Atossa Therapeutics, Inc.

Phase 2 Terminated

3 enrolled 7 charts

Female Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡